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Abstract
HIV-1 is internalized into mature dendritic cells (mDCs) via an as yet undefined mechanism with subsequent transfer of
stored, infectious virus to CD4+ T lymphocytes. Thus, HIV-1 subverts a DC antigen capture mechanism to promote viral
spread. Here, we show that gangliosides in the HIV-1 membrane are the key molecules for mDC uptake. HIV-1 virus-like
particles and liposomes mimicking the HIV-1 lipid composition were shown to use a common internalization pathway and
the same trafficking route within mDCs. Hence, these results demonstrate that gangliosides can act as viral attachment
factors, in addition to their well known function as cellular receptors for certain viruses. Furthermore, the sialyllactose
molecule present in specific gangliosides was identified as the determinant moiety for mDC HIV-1 uptake. Thus, sialyllactose
represents a novel molecular recognition pattern for mDC capture, and may be crucial both for antigen presentation
leading to immunity against pathogens and for succumbing to subversion by HIV-1.
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Introduction
Dendritic cells (DCs) are the most potent antigen-presenting
cells found in the organism and play a paramount role in initiating
immune responses to assaulting pathogens [1,2]. DCs that patrol
the mucosal tissue display an immature phenotype and are able
to capture incoming pathogens, which leads to DC activation,
maturation, and migration to the secondary lymphoid tissue,
where DCs acquire the mature phenotype required to efficiently
induce adaptive immune responses [1].
Given the unique role of DCs in initiating primary immune
responses [1], it is generally believed that these antigen-presenting
cells are critical to induce resistance to infection [2–4]. In the
specific case of viral infections, murine DC depletion models have
provided in vivo evidence of the DC requirement to induce both
humoral and cellular antiviral immune responses [5,6]. However,
some viruses, including HIV-1, have evolved strategies to subvert
DC antiviral activity [7,8]. DCs can even promote HIV-l
dissemination, both through the direct release of new virus
particles after productive infection, and through transmission of
captured viruses to susceptible T cells without DC infection, a
process known as trans-infection (reviewed in [9]). Direct infection
and trans-infection occur to a different extent in immature DCs
(iDCs) and mature DCs (mDCs) (reviewed in [9,10]). The initial
Trojan horse hypothesis suggested that HIV-1 capture by iDCs in
the mucosa may protect the virus from degradation and allow its
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transport to secondary lymphoid organs, facilitating trans-infection
of CD4+ T cells and fueling viral spread [11,12]. However, iDCs
show rapid degradation of captured viral particles [13–15], and
several lines of evidence suggest now that the long-term ability of
iDCs to transfer HIV-1 relies on de novo production of viral
particles after productive infection [14,16,17]. HIV-1 replication
in DCs is generally less productive than in CD4+ T cells (reviewed
in [9,18]), however, probably due to the presence of cellular
restriction factors such as SAMHD1 that limit reverse transcrip-
tion following viral entry [19,20].
Maturation of DCs further reduces their ability to support HIV-
1 replication [21–24], but potently enhances their capacity to trans-
infect bystander CD4+ T cells [15,21,25–27]. Trans-infection
occurs via the infectious synapse, a cell-to-cell contact zone that
facilitates transmission of HIV-1 by locally concentrating virus and
viral receptors [26,28]. Strikingly, poorly macropinocytic mDCs
[29] sequester significantly more complete, structurally intact
virions into large vesicles than actively endocytic iDCs [30], and
retain greater amounts of virus 48 h post-pulse than iDCs
immediately after viral wash [15]. Thus, enhanced mDC trans-
infection correlates with increased HIV-1 capture and a longer life
span of trapped viruses [15,27]. Furthermore, mDCs efficiently
interact with CD4+ T cells in lymphoid tissues; key sites of viral
replication, where naı¨ve CD4+ T cells are activated and turn
highly susceptible to HIV-1 infection [31]. Accordingly, carriage
of HIV-1 by mDCs could facilitate the loss of antigen-specific
CD4+ T cells [32,33], favoring HIV-1 pathogenesis. However, the
molecular mechanism underlying HIV-1 uptake by mDCs
remains largely uncharacterized.
We have previously identified an HIV-1 gp120-independent
mechanism of viral binding and uptake that is upregulated upon
DC maturation [15]. Furthermore, HIV-1 Gag enhanced green
fluorescent protein (eGFP)–expressing fluorescent virus-like parti-
cles (VLPHIV-Gag-eGFP) follow the same trafficking route as wild-
type HIV-1 in mDCs [34], and hence share a common molecular
pattern that governs entry into mDCs. In addition, we also
reported that treatment of HIV-1 or VLP producer cells with
inhibitors of glycosphingolipid biosynthesis yielded particles with
less glycosphingolipids, which exhibited reduced entry into mDCs
[34,35], without affecting net release from producer cells [36].
Thus, we hypothesize that gangliosides in the outer monolayer of
HIV-1 and VLP membranes could act as viral attachment factors
and allow viral recognition and capture by mDCs.
Here we sought to investigate the molecular determinants
involved in viral binding and internalization mediated by mDCs.
Using liposomes to mimic the lipid composition and size of HIV-1,
we demonstrate that gangliosides are the key molecules that
mediate liposome uptake. We extended these observations to
VLPs and HIV-1, characterizing a new role for these glycosphin-
golipids as viral attachment factors. Furthermore, we identify
sialyllactose on HIV-1 membrane gangliosides as a novel
molecular recognition pattern that mediates virus uptake into
mDCs.
Results
Gangliosides Are Required for Viral Capture Mediated by
mDC
Considering that glycosphingolipids are enriched in raft-like
plasma membrane domains [37–39] from where HIV-1 is thought
to bud (reviewed in [40]), we investigated the potential role of
glycosphingolipids for HIV-1 capture by mDCs. The ganglioside
GM3 was previously identified in the membrane of different
retroviruses including HIV-1 [41,42]. We were able to confirm the
presence of GM3 in HIVNL4-3 derived from the T-cell line MT-4
by mass spectrometry (Figure 1A). In addition, we detected several
other gangliosides including GM1, GM2, and GD1 in the HIV-1
membrane (Figure 1A).
To test whether gangliosides in the outer leaflet of HIV-1 or
vesicular membranes can act as attachment factors yielding mDC
uptake, we prepared Texas Red (tRed)-labeled large unilamellar
vesicles (LUV) mimicking the size and lipid composition of HIV-1
(referred to as LUVHIV-tRed and prepared as in [43]) and
containing different gangliosides (Figure S1). All LUVs displayed
equal fluorescence intensities (Figure S2). mDCs were pulsed with
either LUVHIV-tRed or VLPs for 4 h at 37uC and the percentage of
fluorescent cells was determined by fluorescence activated cell
sorting (FACS). Similar to our previous results with infectious
HIV-1 [15], a high percentage of mDCs captured the fluorescent
VLPHIV-Gag-eGFP (Figure 1B). Furthermore, VLPs produced in the
CHO cell line, which is only able to synthesize gangliosides up to
GM3 [44], were also efficiently captured by mDCs (Figure 1C).
Uptake into mDCs was further observed for the murine retrovirus
MuLV (Figure 1D), which was previously shown to also contain
gangliosides [41]. On the other hand, no significant uptake into
mDCs was observed for LUVHIV-tRed, which contained the main
lipid constituents of HIV-1, but were devoid of gangliosides
(p,0.0001, paired t test) (Figures 1B and S3). Uptake into mDCs
remained negative for LUVHIV-tRed containing ceramide (Cer)
(p,0.0001, paired t test) (Figures 1B and S3). This was completely
different when monosialogangliosides such as GM3, GM2, or
GM1a were incorporated into the LUVs; mDCs were able to
capture these liposomes with equal efficiency as VLPHIV-Gag-eGFP
Author Summary
Antigen-presenting cells such as dendritic cells (DCs) are
required to combat infections, but viruses including HIV
have evolved strategies to evade their anti-viral activity. HIV
can enter DCs via a non-infectious endocytic mechanism
and trick them into passing infectious virus on to bystander
CD4+ T cells. Immature DC (iDCs) are characterized by high
endocytic activity and low T-cell activation potential.
Interestingly, several groups have shown that DCs that
have undergone ‘‘‘maturation’’’ (mDCs), a process that
occurs on contact with a presentable antigen, capture
higher numbers of HIV-1 particles than iDCs when they are
matured in the presence of lipopolysaccharide. mDCs move
to the lymph nodes where they have more opportunity to
interact with T cells than iDCs, and thus to pass on infectious
virus. But the molecular mechanism underlying HIV-1
uptake by mDCs has until now been elusive. Here we show
that gangliosides, basic components of the host cell’s
plasma membrane, have an important role in this process.
Gangliosides are known to be incorporated into the viral
envelope membrane during the process of viral particle
budding and here we show that they serve as viral
attachment factors: they are recognized and enable HIV-1
uptake by mDCs. Thus, in addition to the well-known
function of gangliosides as host cell receptors that mediate
virus (e.g., polyoma and SV40) attachment and transport
from the plasma membrane to the ER, we now demonstrate
that they can also act as determinants for capture by mDCs.
Furthermore, we identify a moiety composed of sialyllactose
on HIV-1 membrane gangliosides as the specific domain
recognized by mDCs. We propose that this novel recogni-
tion moiety might be crucial for inducing immune
responses, but also critical to disseminate HIV-1 and other
ganglioside-containing viruses.
Sialyllactose Governs HIV-1 Capture by Mature DCs
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Figure 1. Gangliosides are required for viral capture mediated by mDC. (A) Ganglioside detection in lipid extracts from MT4 derived HIVNL4-3.
Partial mass spectrum (from 850 to 1550 amu) corresponding to the 5.3- and 6.5-min range of a UPLC/TOF ESI (+) chromatogram representative of three
different viral isolations. The selected time range corresponds to the N-hexadecanoyl (N-C16) species. The N-C22, N-C24, and N-C24:1 species were also
observed. For each compound of interest identified, the exact mass of its [M+H]+ and [M+Na]+ ions are indicated. The retention time of each compound
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(Figures 1B and S3). To ensure that this capture was not merely
due to electrostatic interactions between negatively charged
gangliosides and surface charges on mDCs, LUVHIV-tRed contain-
ing negatively charged phosphatidylserine (PS) were analyzed in
parallel and were found to be negative for mDC capture
(p = 0.0081, paired t test) (Figure 1B). These results reveal that
monosialogangliosides mediate LUV capture by mDCs, and that
the carbohydrate head group is essential for this process.
To determine whether ganglioside-containing LUVHIV-tRed and
VLPHIV-Gag-eGFP exploit a common entry mechanism into mDCs,
we performed competition experiments. mDCs were pulsed with
decreasing amounts of GM2-containing LUVHIV-tRed and a
constant amount of VLPHIV-Gag-eGFP for 4 h at 37uC. After
extensive washing, the percentage of eGFP- and tRed-positive cells
was determined by FACS. GM2-containing LUVHIV-tRed effi-
ciently competed for the uptake of VLPHIV-Gag-eGFP into mDCs in
a dose-dependent manner (p,0.0001, paired t test) (Figure 1E).
However, no competition for VLP uptake was observed for
LUVHIV-tRed containing Cer or lacking glycosphingolipids (Figure 1E).
Hence, GM-containing LUVHIV-tRed and VLPHIV-Gag-eGFP
use a common entry mechanism to gain access into mDCs, which is
dependent on the carbohydrate head group.
Ganglioside-Containing LUVHIV-tRed Traffic to the Same
Compartment as VLP HIV-Gag-eGFP in mDCs
We next investigated whether GM-containing LUVHIV-tRed and
VLPHIV-Gag-eGFP reach the same compartment in mDCs using
spinning-disc confocal microscopy. We had previously described three
types of patterns for HIV-1 captured into mDC: random, polarized,
or sac-like compartments [15,45]. The same patterns were also
observed for GM-containing LUVHIV-tRed and the percentage of
mDCs displaying the different patterns was similar regardless of the
particle used (Figure 2A). Thus, VLPHIV-Gag-eGFP and GM-containing
LUVHIV-tRed not only compete for internalization, but also traffic to
an analogous compartment within mDCs. To determine whether
VLPHIV-Gag-eGFP and GM-containing LUVHIV-tRed are captured into
the same compartment, mDCs were pre-incubated 3 h at 37uC with
GM-containing LUVHIV-tRed and subsequently incubated with
VLPHIV-Gag-eGFP for three additional hours. Confocal microscopy of
fixed cells revealed that GM-containing LUVHIV-tRed and VLPs
polarized towards the same cell area in mDCs (Figure S4).
Furthermore, VLPs extensively co-localized with GM-containing
LUVHIV-tRed (including either GM1a, GM2, or GM3) in the same
intracellular compartment (Figure 2B; Video S1).
Capture of Ganglioside-Containing LUVHIV-tRed by mDCs
Is Independent of Membrane Liquid Order
The HIV-1 envelope is a liquid-ordered membrane and
gangliosides are presumably enriched in this type of membranes
[41,43,46,47]. Moreover, ganglioside interaction with cholesterol in
lipid rafts [37,38,47] is known to influence ganglioside conformation
and alter its activity as a cellular receptor [48]. We therefore
assessed whether membrane structure or the specific lipid
composition (other than gangliosides) of the particle membrane
influenced mDC capture. mDCs were incubated with LUVPOPC-tRed
composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) with or without different gangliosides (Figure 3A). In contrast
to LUVHIV-tRed, LUVPOPC-tRed have a liquid-disordered membrane
structure [38]. Results for LUVPOPC-tRed were very similar to
LUVHIV-tRed with efficient capture if either GM1a, GM2, or GM3
was present, while no uptake was observed for Cer containing
LUVPOPC-tRed or LUVPOPC-tRed lacking gangliosides (Figure 3A).
Furthermore, the percentage of mDCs displaying particles in
random, polarized or sac-like compartment capture patterns was
again very similar for the different particles (Figure 3B). These results
show that ganglioside-containing LUVs use the same trafficking
pathway as VLPHIV-Gag-eGFP regardless of their membrane structure,
indicating that gangliosides themselves are the key molecules
responsible for mDC capture.
Ganglioside Complexity Determines mDC Capture
To gain further insight into the molecular determinant structure
required for efficient recognition by mDCs, LUVHIV-tRed carrying
more complex gangliosides were produced, including two, three,
and four sialic acid groups at diverse positions in the carbohydrate
polar head group (di-, tri-, and tetra-sialogangliosides) (Figure 4A).
mDCs pulsed with an equal amount of LUVHIV-tRed-containing
gangliosides with two or three sialic acids (GD1b and GT1b,
respectively) captured these particles with the same efficiency as
GM1a-LUVHIV-tRed (Figure 4A). However, capture was almost
completely lost for LUVHIV-tRed containing a ganglioside with four
sialic acids (GQ1b) (Figure 4A). Accordingly, LUVHIV-tRed
carrying GD1b or GT1b efficiently competed for mDC uptake
with VLPHIV-Gag-eGFP, while no competition was observed for
LUVHIV-tRed carrying GQ1b, PS, or Cer (Figure 4B). These
results indicate that complex gangliosides with up to three sialic
acids located in distinct positions of the carbohydrate head group
share a common structure determinant for mDC uptake, which is
lost in GQ1b.
is given within parenthesis next to its abbreviation. Inset: exact mass ion cluster obtained at 5.56 min for GD1 (a) and exact mass ion cluster
corresponding to the formula C82H144N4O39 with a charge state of 2 (b). X 10 indicates a ten-fold magnification between 1,500 and 1,550 amu. GA2, N-
acetyl-D-galactosaminyl-D-galactosyl-D-glucosylceramide; LacCer, D-galactosyl-D-glucosylceramide (lactosylceramide). (B) Comparative mDC capture of
VLPHIV-Gag-eGFP produced in HEK-293T and distinct fluorescent LUVHIV-tRed containing Cer, GM3, GM2, GM1a, or PS. A total of 2610
5 DCs were pulsed for
4 h at 37uC with 100 mM of LUV or 75 ng of VLPHIV-Gag-eGFP Gag in 0.2 ml, washed with PBS, and assessed by FACS to obtain the percentage of tRed or
eGFP-positive cells. Data show mean values and standard error of the mean (SEM) from five independent experiments including cells from at least six
donors. mDCs capture significantly higher amounts of GM3-containing LUVHIV-tRed than Cer or Ø LUVHIV-tRed (p,0.0001, paired t test). mDCs capture
significantly higher amounts of GM1a-containing LUVHIV-tRed than negatively charged PS-LUVHIV-tRed (p=0.0081, paired t test). Schematic representation
of the gangliosides used in the LUVs for these experiments is shown underneath. (C) Capture of VLPHIV-Gag-eGFP produced in CHO cell line, which is only
able to synthesize gangliosides up to GM3. A total of 26105 mDCs were incubated for 4 h at 37uC with 75 ng of sucrose-pelleted VLPHIV-Gag-eGFP Gag,
washed and analyzed by FACS to determine the percentage of eGFP-positive cells. Data showmean values and SEM from one representative experiment
out of two including cells from three donors. (D) mDC capture of VLPMLV-Gag-YFP. Graph shows mDCs pulsed for 4 h at 37uC with VLPMLV-Gag-YFP, washed
with PBS and assayed by FACS to obtain the percentage of YFP-positive cells. Data show mean values and SEM of cells from three donors. Left image
depicts confocal microscopy analysis of pulsed cells, showing a 3-D reconstruction of the x-y sections collected throughout the whole mDC z volume
every 0.1 mm. Isosurface representation of DAPI-stained nucleus is depicted, computing the maximum intensity fluorescence of the sac-like
compartment surface within a 3-D volumetric x-y-z data field, where VLPMLV-Gag-YFP accumulate within a compartment analogous to that observed for
HIV-1. (E) Capture competition between 75 ng of VLPHIV-Gag-eGFP Gag and decreasing amounts (mM) of GM2-containing LUVHIV-tRed. As controls, we used
themaximum concentration of LUVHIV-tRed (100 mM)with or without Cer. Cells were incubated for 4 h at 37uC, washed and analyzed by FACS to establish
the percentage of eGFP- and tRed-positive cells. Data showmean values and SEM from three independent experiments including cells from at least four
donors. mDCs capture fewer VLPHIV-Gag-eGFP in the presence of higher amounts of GM2-containing LUVHIV-tRed (p,0.0001, paired t test).
doi:10.1371/journal.pbio.1001315.g001
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Figure 2. Ganglioside-containing LUVHIV-tRed traffic to the same compartment as VLP HIV-Gag-eGFP in mDCs. (A) (Top) Fluorescence
images showing the different patterns of 75 ng of VLPHIV-Gag-eGFP Gag and 100 mM of GM1a-containing LUVHIV-tRed capture mediated by mDCs:
random binding, polarized accumulation, and formation of a sac-like compartment. 3-D reconstructions of the x-y sections were performed collecting
images every 0.1 mm throughout the whole mDC volume. Isosurface representation of DAPI-stained nucleus is shown, computing the maximum
intensity of the green and red fluorescence within a 3-D volumetric x-y-z data field. (Bottom) Percentage of mDCs with distinct capture patterns after
4 h of independent challenging with VLPHIV-Gag-eGFP or ganglioside-containing LUVHIV-tRed. Cells were classified using confocal microscopy displaying
particles as indicated in the top images. Data show mean values and SEM of more than 100 cells from five different donors. (B) Confocal microscopy
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Identification of the Molecular Recognition Domain
Present in Gangliosides That Is Essential for mDC Capture
The lack of internalization of Cer-containing LUVs indicated
that the carbohydrate head group is specifically required for mDC
capture. Sialic acid has previously been identified as a cellular
receptor for certain viruses [49]. We therefore tested its
importance for mDC capture. Incubation of mDCs with equal
concentrations of LUVHIV-tRed containing Cer, GM1a, or GM1
without the sialic acid group (Asialo GM1) revealed sialic acid-
dependent capture (Figure 5A). In addition, in situ neuraminidase
treatment of GM3-containing LUVHIV-tRed and VLPHIV-Gag-eGFP,
significantly reduced particle capture (Figure 5B) and LUV
binding to mDCs (Figure S5). Thus, the sialic acid moiety in
gangliosides is necessary for specific recognition by mDCs. To
assess the contribution of other components of the carbohydrate
head group, we prepared LUVHIV-tRed containing either GM4
(lacking the glucose moiety of GM3) (Figure 5C) or GalCer
(lacking both the glucose and sialic acid moieties of GM3)
(Figure 5C). mDCs incubated with GM4- or GalCer-containing
LUVHIV-tRed showed only background levels of liposome capture
(Figure 5C), indicating that the glucose moiety of sphingolipids is
also necessary for mDC capture.
Given that the carbohydrate moiety within gangliosides
constitutes the molecular recognition determinant for mDC
capture, these head groups should compete for VLP and LUV
uptake. Capture of GM3-containing LUVHIV-tRed or VLPHIV-Gag-
eGFP by mDCs was completely blocked in the presence of the GM3
polar head group (sialyllactose), while equal concentrations of
lactose (lacking the sialic acid group) had no effect (Figure 5D).
Taken together, these data clearly show that the sialyllactose
moiety of gangliosides is the molecular determinant required for
efficient VLP and LUV recognition and capture by mDCs.
Noteworthy, the high concentrations of the GM3 head group
required for competition in Figure 5D compared to the low
concentrations of gangliosides in LUVs needed to outcompete
VLPs (,1,000-fold less) (Figure 1C) suggests that the attachment
of sialyllactose to Cer within membranes confers a higher binding
avidity. This is not surprising since viruses and toxins are
multivalent: for instance, the VP1 capsid protein of SV40 is
pentameric and the cholera toxin is pentavalent; both bind five
GM1 molecules [50–52]. In addition, the hydrophilic moiety of
Cer in the membrane interface could be part of the recognition
domain, directly increasing the binding affinity to mDCs.
Modeling of the 3-D structure of gangliosides (Figure S6)
suggested that mDC recognition required an exposed sialyllactose
domain and that the lack of recognition of GQ1b could be caused
by steric hindrance (Figure S6). Thus, although the lipid and
protein context of surrounding membranes might influence the
biologically active conformation of gangliosides [48,53]; 3-D
reconstructions provide a structural basis to explain the distinct
recognition patterns observed for different gangliosides. The
sialyllactose recognition domain defined in this study differs from
the NeuAc a 2,3Gal b 1,3GalNAc on gangliosides identified as
host cell receptors for SV40 and Sendai virus, and for cholera
and tetanus toxin [50,52,54], but is identical with the a 2,3-
sialyllactose identified as host cell receptor for other paramyxo-
viruses [55,56].
Sialyllactose in Membrane Gangliosides Is Required for
mDC Uptake and Trans-infection of HIV-1
To determine whether the results obtained with LUVs and
VLPs also hold true for the authentic virus, we performed
experiments with wild-type HIVNL4-3 produced in primary T cells.
Similar to our previous data [15], a high percentage of mDCs
captured HIV-1, while uptake into iDCs was much less efficient
(p = 0.0047, one sample t test) (Figure 6A). To confirm the
importance of viral gangliosides for mDC capture, we purified
HIVNL4-3 from primary CD4
+ T cells pre-treated or not with the
glycosphingolipid biosynthesis inhibitor NB-DNJ. HIV-1 capture
was strongly reduced for virus obtained from inhibitor-treated cells
compared to control virus (p,0.0001, one sample t test)
(Figure 6B). To directly determine the importance of the
sialyllactose head group for mDC capture of authentic HIV-1,
we performed competition experiments showing a strong reduc-
tion of virus capture in the presence of the GM3 polar head group,
but not in the presence of lactose (p,0.0001, one sample t test)
(Figure 6C). These data confirm the observations obtained with
liposomes and VLPs for authentic HIV-1 from primary CD4+ T
cells.
HIV-1 capture by mDCs has been shown to promote trans-
infection of CD4+ T cells and other target cells [15,21,25–27],
and we therefore analyzed whether sialyllactose recognition by
mDCs is also important for viral transmission. Co-culturing
mDCs that had been exposed to an equivalent amount of
infectious HIVNL4-3 derived from NB-DNJ-treated or untreated
CD4+ T cells with the TZM-bl reporter cell line revealed a strong
reduction of trans-infection for the virus from inhibitor-treated
cells compared to control virus (p = 0.0404, paired t test)
(Figure 6D). We also observed a strong reduction of trans-
infection for mDCs pulsed with HIVNL4-3 in the presence of the
GM3 polar head group and subsequently incubated with TZM-bl
cells (Figure 6E) (p = 0.0197, paired t test). These results were
further confirmed when we co-cultured HIV-1-pulsed mDCs
with activated primary CD4+ T cells. Co-cultures were
performed in the presence or absence of the protease inhibitor
saquinavir to distinguish net trans-infection from re-infection
events (Figure 6F and 6G; left and right panels, respectively).
Infection of primary CD4+ T cells was strongly enhanced when
they were co-cultured with HIV-1 pulsed mDCs (Figure 6F and
6G; filled bars). This effect was abrogated when mDCs were
pulsed with virus produced from NB-DNJ-treated cells (Figure 6F)
or cultured with the GM3 polar head group (Figure 6G). These
data indicate that the sialyllactose moiety of gangliosides is the
molecular determinant required for efficient HIV-1 capture by
mDCs and for subsequent viral trans-infection.
Discussion
Sialic acid on gangliosides has previously been shown to
function as host cell receptor for several viruses [54,57,58] and for
human toxins [52]. The current study clearly identifies a novel role
analysis of mDCs previously pulsed with 100 mM of GM1a, GM2, and GM3 containing LUVHIV-tRed and then exposed to 75 ng of VLPHIV-Gag-eGFP Gag.
(Top images) 3-D reconstructions of the x-y sections collected throughout the whole mDC z volume every 0.1 mm. Isosurface representation of DAPI
stained nucleus is shown, computing the maximum intensity fluorescence of the sac-like compartment surface within a 3-D volumetric x-y-z data
field, where VLPHIV-Gag-eGFP and ganglioside-containing LUVHIV-tRed are accumulated within the same compartment. (Bottom graphs) Quantification of
the percentage of VLPHIV-Gag-eGFP co-localizing with ganglioside-containing LUVHIV-tRed and vice versa, obtained analyzing at least ten compartments
from mDCs of three different donors. The mean and standard deviation of the thresholded correlation coefficients of Manders and Pearson (obtained
considering all the images) were 0.75260.03 and 0.4460.11, respectively, indicating co-localization.
doi:10.1371/journal.pbio.1001315.g002
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Figure 3. Capture of ganglioside-containing LUVHIV-tRed by mDCs is independent of membrane liquid order. (A) Comparative mDC
capture of LUVPOPC-tRed containing or not Cer, GM3, GM2, or GM1a. A total of 2610
5 DCs were pulsed for 4 h at 37uC with 100 mM of LUVs, washed
with PBS, and assessed by FACS to obtain the percentage of tRed-positive cells. Data show mean values and SEM from three independent
experiments including cells from at least six donors. mDCs capture significantly higher amounts of GM3-containing LUVPOPC-tRed than Cer or LUVPOPC-
tRed (p-values on the graph, paired t test). (B) (Top images) Fluorescence images showing the different phases of ganglioside-containing LUVPOPC-tRed
capture mediated by mDCs: random binding, polarized accumulation, and formation of a sac-like compartment. 3-D reconstructions of the x-y
sections were performed collecting images every 0.1 mm throughout the whole mDC z volume. Isosurface representation of DAPI stained nucleus is
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for sialylated gangliosides in the membrane of viruses or LUVs as
determinants for specific capture by mDCs. This recognition is
reminiscent of the engulfment of apoptotic cells by phagocytes
such as DCs, which is triggered by PS, a phospholipid normally
found in the inner leaflet of the plasma membrane of living cells,
but exposed on the surface of dying cells [59]. However, the viral
capture described here is dependent on an exposed sialyllactose
moiety on gangliosides, which we identified as a novel molecular
recognition pattern. The ganglioside GM3 was previously detected
in the membrane of HIV-1 and several other viruses (SFV, VSV,
MuLV) [41,42], and this was extended to GM1, GM2, and GD1
for HIV-1 in the present study. Gangliosides are significant
components of the plasma membrane lipidome [42], suggesting
that all enveloped viruses, which bud from the plasma membrane
of infected cells, may be captured into mDCs by the reported
mechanism unless they exclude sialyllactose-containing ganglio-
sides. Most studies of viral lipidomes have not included
gangliosides so far, however, and it will be important to determine
whether certain viruses have developed mechanisms to prevent
sialyllactose presentation on their membrane lipids. This would be
conceivable for influenza virus, which carries a viral neuramin-
idase needed for removal of the sialic acid receptor from the
producer cell surface, thus allowing virus release. This neuramin-
idase may also remove sialic acid groups from viral gangliosides,
thus preventing mDC uptake and potential antigen presentation.
Consequently, neuraminidase inhibitor treatment should lead to
increased DC capture and potentially enhance immunogenicity of
influenza virus or VLPs. Moreover, viral ganglioside content may
vary depending on the membrane composition of the producer
cell. Viral replication in the nervous system, where gangliosides are
particularly enriched [60], may thus lead to the insertion of an
increased amount of distinct gangliosides into virions, affecting
mDC recognition and local immunosurveillance.
The potential immunological role of mDC uptake implies
efficient antigen capture and processing throughout the antigen
presentation pathway. Interestingly, antigen-bearing cellular secret-
ed vesicles known as exosomes also follow the same trafficking route
as HIV-1 [34] and contain gangliosides such as GM3 or GM1 [61].
Hence, sialyllactose-carrying gangliosides in the membrane of
viruses and cellular vesicles are targeting molecules for mDC
uptake, a pathway that may normally lead to antigen processing and
presentation and has been subverted by HIV-1 for infectious virus
storage and transmission. Furthermore, although downregulation of
endocytosis is considered a hallmark of DC maturation (reviewed in
[3]), there is increasing evidence that under inflammatory
conditions mDCs capture, process, and present antigens without
exclusively relying on prior pathogen exposure [62,63]. This
scenario might be particularly relevant in chronic infections, such
as the one caused by HIV-1, where translocation of bacteria from
the intestinal lumen [64] could stimulate DCs systemically and
contribute to sustained antiviral immune responses. Remarkably,
HIV-1 infected patients show enhanced GM3 content in the plasma
membrane of T lymphocytes and high titers of anti-lymphocytic
GM3 antibodies [65,66].
Paradoxically, HIV-1 capture into mDCs appears to also
critically enhance viral dissemination in lymphoid tissue by
efficient release of infectious virus to CD4+ T cells in the DC-T-
cell synapse, thus promoting pathogenesis and disease progression
through trans-infection. Hence, although myeloid cells are largely
refractory to productive HIV-1 infection due to the presence of
cellular restriction factors such as the recently identified SAMHD1
[19,20], the sialyllactose driven trans-infection process character-
ized here in mDCs seems to exploit a pre-existing cellular-
trafficking machinery that avoids the activation of these intrinsic
immune pathways.
The efficient capture of ganglioside-carrying cellular vesicles or
virions suggests a model where a specific receptor present on the
cell surface of mDCs (and possibly other cells) recognizes the
sialyllactose moiety on virions or vesicle membranes. Gangliosides
have been reported to function as cell adhesion molecules [67],
and this may also involve such a receptor. Specific recognition of
vesicular gangliosides would then trigger uptake of the respective
particles into an intracellular compartment from where they are
either recycled to the surface (as in HIV-1 transmission to CD4+ T
cells) or fed into the antigen presentation pathway. The results of
the current study identify sialyllactose on membrane gangliosides
as the relevant molecular recognition pattern, explaining the
specificity of this process and providing the basis for its future
exploitation for interventional or vaccine purposes.
Materials and Methods
Ethics Statement
The institutional review board on biomedical research from
Hospital Germans Trias i Pujol approved this study.
Isolation of HIV-1 and Mass Spectrometry Analysis
MT-4 cells were infected with HIVNL4-3 and co-cultured with
uninfected cells. Virus was harvested before cytopathic effects were
observed, and purified essentially as described in [43]. Briefly,
medium was cleared by filtration, and particles were concentrated
by ultracentrifugation through a cushion of 20% (w/w) sucrose.
Concentrated HIV-1 was further purified by velocity gradient
centrifugation on an OptiPrep gradient (Axis-Shield). The visible
virus fraction was collected and concentrated by centrifugation.
The final pellet was resuspended in 10 mM Hepes, 150 mM
NaCl, pH 7.4 (hepes-sodium buffer), rapidly frozen in liquid
nitrogen and stored at 280uC. For lipid composition analysis,
samples were resuspended in methanol upon thawing and then
assessed in a UPLC coupled to an orthogonal acceleration time-of-
flight mass spectrometer with an electrospray ionization interface
(LCT Premier; Waters) using the procedure previously described
in [68]. Data were acquired using positive ionization mode over a
mass range of m/z 50–1,500 in W-mode. A scan time of 0.15 s
and interscan delay of 0.01 s were used at a nominal instrument
resolution of 11,500 (FWHM). Leucine enkephalin was used as the
lock spray calibrant.
Primary Cell Cultures
Peripheral blood mononuclear cells (PBMCs) were obtained
from HIV-1-seronegative donors and monocyte populations
(.97% CD14+) were isolated with CD14+-positive selection
magnetic beads (Miltenyi Biotec). DCs were obtained culturing
these cells in the presence of 1,000 IU/ml of granulocyte-
macrophage colony-stimulating factor (GM-CSF) and interleu-
kin-4 (IL-4; R&D). mDCs were differentiated by culturing iDCs at
day five for two more days in the presence of 100 ng/ml of
lipopolysaccharide (LPS; Sigma). DCs were immunophenotyped
shown, computing the maximum intensity of the green and red fluorescence within a 3-D volumetric x-y-z data field. (Bottom graph) Percentages of
mDCs with distinct liposome capture pattern after 4 h of ganglioside-containing LUVPOPC-tRed challenging. Cells were classified using confocal
microscopy displaying particles as indicated in the top images. Data show mean values and SEM of more than 100 mDCs from three different donors.
doi:10.1371/journal.pbio.1001315.g003
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Figure 4. Ganglioside complexity determines mDC capture. (A) Comparative mDC capture of distinct LUVHIV-tRed containing GM1a,
polysialogangliosides such as GD1b, GT1b, and GQ1b; PS and Cer. A total of 26105 DCs were pulsed for 4 h at 37uC with 100 mM of LUVs, washed
with PBS, and assessed by FACS to obtain the percentage of tRed-positive cells. Data show mean values and SEM from two independent experiments
including cells from six donors. mDCs capture significantly higher amounts of GM1a-containing LUVHIV-tRed than GQ1b-containing LUVHIV-tRed
(p,0.0001, paired t test). Schematic of the gangliosides in the LUVs employed for these experiments is shown underneath. (B) Capture competition
between mDCs pulsed with 75 ng of VLPHIV-Gag-eGFP Gag and 100 mM of different polysialogangliosides LUVHIV-tRed. Cells were incubated for 4 h at
37uC, washed, and analyzed by FACS to determine the percentage of eGFP- and tRed-positive cells. Data show mean values and SEM from two
independent experiments including cells from six donors. mDCs capture fewer VLPHIV-Gag-eGFP in the presence of GM1a-containing LUVHIV-tRed than in
the presence of the same concentration of GQ1b containing LUVHIV-tRed (p,0.0001, paired t test). Representative fluorescence images from mDCs
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at day 7 as previously described [15]. Adequate differentiation
from monocytes to iDCs was based on the loss of CD14 and the
acquisition of DC-SIGN, while DC maturation upregulated the
expression of CD83, CD86, and HLA-DR. CD4+ T lymphocytes
required for trans-infection experiments were isolated from PBMCs
with CD4-negative selection magnetic beads (Miltenyi Biotec) and
stimulated for 72 h in the presence of 10 IU/ml of IL-2 (Roche)
and 3 mg/ml of phytohaemagglutinin (PHA; SigmaAldrich).
Primary cells were maintained in RPMI with 10% fetal bovine
serum (FBS), 100 IU/ml of penicillin and 100 mg/ml of
streptomycin (all from Invitrogen).
Cell Lines, Plasmids, and Viral Stocks
HEK-293T and TZM-bl (obtained through the US National
Institutes of Health [NIH] AIDS Research and Reference Reagent
Program, from JC Kappes, X Wu, and Tranzyme Inc.) were
maintained in D-MEM (Invitrogen). CHO cell line was main-
tained in a-MEM. MT4 cell line was maintained in RPMI. All
media contained 10% FBS, 100 IU/ml of penicillin, and 100 mg/
ml of streptomycin. VLPHIV-Gag-eGFP were obtained transfecting
the molecular clone pGag-eGFP (obtained through the NIH AIDS
Research and Reference Reagent Program, from MD Resh).
VLPMLV-Gag-YFP were obtained transfecting the molecular clone
pGag-MLV wt [69]. HEK-293T cells were transfected with
calcium phosphate (CalPhos, Clontech) in T75 flasks using 30 mg
of plasmid DNA. CHO cells were electroporated (0.24 Kv and
950 mF) using 76106 cells and 40 mg of plasmid DNA.
Supernatants containing VLPs were filtered (Millex HV,
0.45 mm; Millipore) and frozen at 280uC until use. For studies
with concentrated VLPs, medium was harvested, cleared by
filtration, and particles were concentrated by ultracentrifugation
(28,000 rpm 2 h at 4uC in SW32 rotor) through 20% (w/w)
sucrose. The final pellet was resuspended in hepes-sodium buffer,
rapidly frozen in liquid nitrogen, and stored at 280uC. The
p24Gag content of the MT4-derived viral stock and VLPHIV-Gag-eGFP
was determined by an ELISA (Perkin-Elmer) and by a quantitative
Western blot. Detection was carried out with a LiCoR Odyssey
system employing our own Rabbit anti-capsid polyclonal antibody
and a purified Gag protein (kindly provided by J Mak) as a standard.
To produce HIVNL4-3 in PBMCs, cells were stimulated with 3 mg/
ml PHA and 10 IU/ml of IL-2 for 72 h prior to infection with
HIVNL4-3. To generate HIVNL4-3 in CD4
+ T cells, whole blood from
three HIV-1–seronegative donors were CD8+ T cell depleted using
Rossettesep anti-CD8+ cocktail (Stem cell). Enriched CD4+ T cells
were pooled and stimulated under three different conditions: low-
dose PHA (0.5 mg/ml), high-dose PHA (5 mg/ml), or plate-bound
anti-CD3 monoclonal antibody OKT3 (e-Bioscience) [70]. After
72 h, cells were mixed together, infected with HIVNL4-3 and
resuspended to a final concentration of 106 cells/ml in RPM1 with
10% FBS supplemented with 100 IU/ml of IL-2. To produce
glycosphingolipid deficient HIVNL4-3, enriched CD4
+ T cells were
kept in the presence or absence of 500 mM of NB-DNJ (Calbiochem)
and 10 IU/ml of IL-2 for 6 d before stimulation with 3 mg/ml of
PHA and subsequent infection with HIVNL4-3. Virus growth was
monitored by p24Gag ELISA (Perkin Elmer). Supernatants were
harvested when the concentration of p24Gag was at least 102 ng/ml,
filtered and stored at 280uC until use. Titers of all viruses were
determined using the TZM-bl indicator cell line as described
elsewhere [71].
Production of Liposomes
LUVs were prepared following the extrusion method described in
[72]. Lipids were purchased from Avanti Polar Lipids and
gangliosides were obtained from Santa Cruz Biotechnology.
Ganglioside source was bovine brain with the exception of GM4,
which was from human brain. The LUVHIV-tRed lipid composition
was: POPC 25 mol%: 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC) 16 mol%: brain sphingomyelin (SM) 14 mol%: cholesterol
(Chol) 45 mol%, and when Cer, PS, or gangliosides were present
(4 mol%) the SM amount was reduced to 10 mol%. The LUVPOPC-
tRed lipid composition was 96 mol% POPC containing or not
4 mol% of Cer, GM3, GM2, or GM1a. All the LUVs contained
2 mol% of 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine
(DHPE)-tRed (Molecular Probes). Lipids were mixed in chloro-
form:methanol (2:1) and dried under nitrogen. Traces of organic
solvent were removed by vacuum pumping for 1–2 h. Subse-
quently, the dried lipid film was dispersed in hepes-sodium buffer
and subjected to ten freeze-thaw cycles prior to extruding ten
times through two stacked polycarbonate membranes with a 100-
nm pore size (Nucleopore, Inc.) using the Thermo-barrel
extruder (Lipex extruder, Northern Lipids, Inc.). In order to
perform mDC pulse with equal concentrations of LUV displaying
similar fluorescence intensities, tRed containing LUVs concen-
tration was quantified following the phosphate determination
method of [73] and the fluorescence emission spectra was
recorded setting the excitation at 580 nm in a SLM Aminco
series 2 spectrofluorimeter (Spectronic Instruments).
Liposome and VLP Capture Assays
All capture experiments were performed pulsing mDCs in
parallel at a constant rate of 100 mM of distinct LUVtRed
formulations and 75 ng of VLPHIV-Gag-eGFP Gag quantified by
western blot (2,500 pg of VLPHIV-Gag-eGFP p24
Gag estimated by
ELISA) per 26105 cells for 4 h at 37uC. After extensive washing,
positive DCs were acquired by FACS with a FACSCalibur (BD)
using CellQuest software to analyze collected data. Forward-angle
and side-scatter light gating were used to exclude dead cells and
debris from all the analysis.
Competition experiments were done incubating 26105 mDCs
with 75 ng of VLPHIV-Gag-eGFP Gag at a final concentration of
16106 cells/ml for 4 h at 37uC in the presence of decreasing
amounts of GM2-containing LUVHIV-tRed or 100 mM of Cer- and
PS-containing LUVHIV-tRed. Alternatively, cells were incubated
with 75 ng of VLPHIV-Gag-eGFP Gag and 100 mM of LUVHIV-tRed
including or not GM1a, GD1b, GT1b, GQ1b, Cer, and PS. Cells
were then analyzed by FACS as previously described.
Confocal Microscopy Analysis
Co-localization experiments were done pulsing mDCs sequen-
tially with LUVHIV-tRed and VLPHIV-Gag-eGFP for 3 h as described
in the capture assays section. Capture patterns were analyzed
similarly, incubating cells with distinct LUVHIV-tRed and
VLPHIV-Gag-eGFP separately. After extensive washing, cells were
fixed and cytospun into glass slides, mounted in DAPI-containing
fluorescent media and sealed with nail polish to analyze them in a
spinning disk confocal microscope. Z-sections were acquired at 0.1-
mm steps using a 606 Nikon objective. Spinning disk confocal
microscopy was performed on a Nikon TI Eclipse inverted optical
microscope equipped with an Ultraview spinning disk setup
exposed to the indicated LUVHIV-tRed in these experiments are shown in the bottom of the graph. Isosurface representation of DAPI stained nucleus is
shown, computing the maximum intensity of the green and red fluorescence within a 3-D volumetric x-y-z data field.
doi:10.1371/journal.pbio.1001315.g004
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(PerkinElmer) fitted with a two CCD camera (Hamamatsu). The co-
localization signals in percentages of the compartment area and the
thresholded Manders and Pearson coefficients were calculated for
each image using Volocity 5.1 software (Improvision). To obtain 3-
D reconstructions, confocal Z stacks were processed with Volocity
5.1 software, employing the isosurface module for the nucleus and
the maximum fluorescent intensity projection for LUVs and VLPs.
Neuraminidase Treatment of VLPs and LUVs
A total of 26105 DCs were pulsed for 2 h at 37uC with 25 mM
of GM3-containing LUVHIV-tRed and 75 ng of sucrose-pelleted
VLPHIV-Gag-eGFP Gag treated or not during 12 h at 37uC with 100
or 50 mU of neuraminidase from Clostridium perfringens Factor X
(Sigma Aldrich). The 12-h incubation was done in a glass-coated
plate (LabHut) in hepes-sodium buffer, and the reaction was
stopped adding RPMI media containing FBS. Cells were washed
and assessed by FACS to obtain the percentage of tRed- and
eGFP-positive cells.
Lactose and GM3 Polar Head Group Treatment of mDCs
mDCs were preincubated with or without 5 or 10 mM of
lactose (Sigma-Aldrich) and soluble GM3 carbohydrate head
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Figure 5. Identification of the molecular recognition domain present in gangliosides essential for mDC capture. (A) Comparative mDC
capture of distinct LUVHIV-tRed containing Cer, GM1a, or GM1 lacking sialic acid (Asialo GM1). A total of 2610
5 DCs were pulsed for 4 h at 37uC with
100 mM of LUVs, washed with PBS, and assessed by FACS to obtain the percentage of tRed-positive cells. Data show mean values and SEM from three
independent experiments, including cells from nine donors. mDCs capture significantly higher amounts of GM1a-containing LUVHIV-tRed than Asialo
GM1-containing LUVHIV-tRed (p,0.0001, paired t test). Schematic of the gangliosides present in the LUVs of these experiments is shown underneath.
(B) Comparative mDC capture of GM3-containing LUVHIV-tRed and VLPHIV-Gag-eGFP treated or not with neuraminidase to remove sialic acid. A total of
26105 DCs were pulsed for 2 h at 37uC with 25 mM of LUVs and 75 ng of VLPHIV-Gag-eGFP Gag treated or not with C. perfringens neuraminidase for 12 h,
washed with PBS, and assessed by FACS to obtain the percentage of tRed- and eGFP-positive cells. Data show mean values and SEM from two
independent experiments including cells from five donors. mDCs capture significantly higher amounts of untreated particles than neuraminidase-
treated particles (p-values on the graph, paired t test). (C) Comparative mDC capture of distinct LUVHIV-tRed containing GalCer, GM4, GM3, or GM1a. A
total of 26105 DCs were pulsed for 4 h at 37uC with 100 mM of LUVs, washed, and assessed by FACS to obtain the percentage of tRed-positive cells.
Data show mean values and SEM from three independent experiments including cells from nine donors. mDCs capture significantly higher amounts
of GM1a-containing LUVHIV-tRed than GalCer or GM4-containing LUVHIV-tRed (p,0.0001, paired t test). Schematic of the molecules present in the LUVs
for these experiments is shown underneath. (D) Graph representing the relative capture of GM3-containing LUVHIV-tRed and VLPHIV-Gag-eGFP by mDCs
that had been pre-incubated with 10 mM of soluble lactose or with 5–10 mM of GM3 carbohydrate polar head group, normalized to the level of LUV/
VLP capture by mock-treated mDCs (set at 100%). mDCs captured fewer particles upon treatment with GM3 polar head group (p-values on the graph,
paired t test). Data show mean values and SEM from three independent experiments including cells from at least nine donors.
doi:10.1371/journal.pbio.1001315.g005
Sialyllactose Governs HIV-1 Capture by Mature DCs
PLoS Biology | www.plosbiology.org 11 April 2012 | Volume 10 | Issue 4 | e1001315
P=0.0047
A
20
40
60
80
100
0 mDCs iDCs
20
40
60
80
100
0
NB-DNJ
]Mµ[ 0 005
P<0.0001
B
20
40
60
80
100
0
%
 H
IV
-1
 NL
4.
3 C
ap
tu
re
d
GM3 
Head Group 
10 0 [mM]10 
Lactose
P<0.0001
C
0
20
40
60
80
100
NB-DNJ
]Mµ[ 0 005
P=0.0404
0
50
100
150
GM3 Head Group 
]Mm[ 0  01
P=0.0197
E
R
LU
s 
(x
 1
00
) w
ith
 S
Q
V
D
0
1
2
3
4
0
2.5
5
7.5
10P=0.0382
NB-DNJ
5000 [µM]
NB-DNJ
5000 [µM]
0
1
2
3
0
5
10
15
20
25
GM3 Head Group 
10 0 [mM]
GM3 Head Group 
10 0 [mM]
P=0.001 P=0.0001
mDCs+CD4
CD4 alone
%
 C
D
4+
 T
 c
ell
s 
p2
4G
ag
 +
 w
ith
 S
Q
V
F
G
R
LU
s 
(x
 1
00
) w
ith
 S
Q
V
%
 C
D
4+
 T
 c
ell
s 
p2
4G
ag
 +
 
wi
th
ou
t  S
Q
V
%
 H
IV
-1
 NL
4.
3 C
ap
tu
re
d
%
 H
IV
-1
 NL
4.
3 C
ap
tu
re
d
mDC mDC mDCTZM-bl CD4
%
 C
D
4+
 T
 c
ell
s 
p2
4G
ag
 +
 w
ith
 S
Q
V
%
 C
D
4+
 T
 c
ell
s 
p2
4G
ag
 +
 
wi
th
ou
t  S
Q
V
mDCs+CD4
CD4 alone
Figure 6. Sialyllactose in membrane gangliosides is required for mDC uptake and trans-infection of HIV-1. (A) Relative capture of
HIVNL4-3 produced in primary cells by mDCs and iDCs. DCs were pulsed for 4 h at 37uC with equal amounts of a HIVNL4-3 produced in stimulated
PBMCs, extensively washed, and then assayed for cell-associated p24Gag content by ELISA. Results are expressed as the percentage of HIVNL4-3
captured by iDCs relative to mDCs, normalized to 100% of viral capture. Viral uptake was increased in mDCs compared to iDCs (p= 0.0047, one
sample t test). Data show mean values and SEM from two independent experiments including cells from three donors. (B) Relative capture of HIVNL4-3
produced in CD4+ T cells that had been treated or not with the glycosphingolipid inhibitor NB-DNJ. mDCs were pulsed for 4 h at 37uC with equal
amounts of HIVNL4-3 generated in NB-DNJ-treated or mock-treated CD4
+ T cells and then assayed for p24Gag content. mDCs captured less HIVNL4-3
generated in NB-DNJ-treated CD4+ T cells (p,0.0001, one sample t test). Data show mean values and SEM from two independent experiments
including cells from six donors. (C) Competition of HIVNL4-3 capture by mDCs in the presence of the GM3 head group. mDCs were either pre-
incubated with 10 mM lactose, 10 mM GM3 head group, or mock treated, and were then pulsed for 4 h at 37uC with equal amounts of HIVNL4-3
generated in CD4+ T cells. Virus uptake was assayed by ELISA for p24Gag. HIVNL4-3 capture was strongly reduced upon pre-treatment with the GM3
head group, but not lactose (p,0.0001, one sample t test). Data show mean values and SEM from two independent experiments including cells from
six donors. (D) Transmission of HIVNL4-3 produced in NB-DNJ or mock-treated CD4
+ T cells to the TZM-bl target cell line, which expresses the luciferase
gene under control of the HIV LTR. mDCs treated as described in (B) but pulsed with an equal MOI of 0.1 were extensively washed and co-cultured
with TZM-bl cells in the presence of saquinavir (to prevent second round infection) for 48 h before measurement of luciferase activity. Trans-infection
was less efficient for HIVNL4-3 generated in NB-DNJ-treated compared to untreated CD4
+ T cells (p= 0.0404, paired t test). Data show mean values and
SEM from one experiment including cells from three donors. (E) Competition of trans-infection of HIVNL4-3 in the presence of the GM3 head group.
mDCs treated as described in (C) but pulsed with an MOI of 0.1 were extensively washed and co-cultured with TZM-bl in the presence of saquinavir
for 48 h before measurement of luciferase activity. Trans-infection was significantly reduced by the GM3 head group (p=0.0197, paired t test). Data
show mean values and SEM from two independent experiments including cells from six donors. (F) Trans-infection of activated primary CD4+ T cells
by co-culture with mDCs pulsed with HIVNL4-3 produced in NB-DNJ or mock- treated CD4
+ T cells. mDCs were pulsed with HIVNL4-3 at an equivalent
MOI of 0.1 as described in (B). Unwashed pulsed mDCs were subsequently co-cultured with primary CD4+ T cells for 48 h before measuring the
intracellular p24Gag content in the lymphocyte gate (CD2+ and CD11c2 cells) by FACS (filled bars). Equivalent amounts of cell-free HIVNL4-3 were used
as a control (open bars). Experiments were done in the presence (left panel) or absence (right panel) of saquinavir to distinguish net trans-infection
from re-infection events, respectively. mDCs transferred less HIVNL4-3 generated in NB-DNJ-treated CD4
+ T cells (p=0.0382, paired t test). Data show
mean values and SEM from one representative experiment including cells from three donors. (G) Trans-infection of activated primary CD4+ T cells by
co-culture with mDCs pulsed with HIVNL4-3 in the presence or absence of the GM3 head group. mDCs were pulsed with HIVNL4-3 at an equivalent MOI
of 0.1 as described in (C). Unwashed pulsed mDCs were subsequently co-cultured with primary CD4+ T cells for 48 h before measuring the
intracellular p24Gag content in the lymphocyte gate (CD2+ and CD11c2 cells) by FACS, as detailed in (F). mDCs transferred less HIVNL4-3 upon
treatment with the GM3 head group (p-values on the graph, paired t test). Data show mean values and SEM from two independent experiments
including cells from six donors.
doi:10.1371/journal.pbio.1001315.g006
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group (Carbosynth) for 30 min at RT. Cells were then pulsed with
50 mM of GM3-containing LUVHIV-tRed and 75 ng of sucrose-
pelleted VLPHIV-Gag-eGFP Gag for 2 h at 37uC, at a final
concentration of 5 or 10 mM for the compounds tested. Cells
were analyzed by FACS as described previously. For experiments
with HIVNL4-3 generated in primary CD4
+ T cells, mDCs were
equally pre-incubated with lactose and the GM3 head group.
Minimize Energy Structures of Gangliosides
Minimal energy structures in vacuum were computed using
Chem3D Ultra software employing the MM2-force field and the
steepest-descent algorithm. Minimum root mean square gradient
was set to 0.1; minimum and maximum move to 0.00001 and 1.0,
respectively.
Dendritic Cell capture and Trans-infection of HIVNL4-3
mDCs and iDCs (56105 cells) were exposed to 30 ng p24Gag of
HIVNL4-3 obtained from stimulated PBMCs for 4 h at 37uC. Cells
were washed thoroughly to remove unbound particles, lysed, and
assayed for cell-associated p24Gag content by an ELISA. mDCs
(2.56105 cells) were exposed to 50 ng p24Gag of HIVNL4-3
obtained from CD4+ T cells treated or not with NB-DNJ,
incubated and assayed as previously described to detect the cell-
associated p24Gag. Alternatively, mDCs (2.56105 cells) pre-
incubated or not with GM3 or lactose as previously indicated
were exposed to 90 ng p24Gag of HIVNL4-3 obtained from CD4
+ T
cells and assayed equally. For trans-infection assays, mDCs were
pulsed equally but with a constant multiplicity of infection (MOI)
of 0.1, extensively washed and co-cultured in quadruplicate with
the TZM-bl reporter cell line at a ratio of 104:104 cells in the
presence of 0.5 mM of saquinavir to assay luciferase activity 48 h
later (BrightGLo luciferase system; Promega) in a Fluoroskan
Ascent FL luminometer. Background values consisting of non-
HIV-1 pulsed co-cultures were subtracted for each sample (mean
background of 8.668 RLUs6100). Trans-infection to primary cells
was performed similarly, co-culturing pulsed mDCs with activated
primary CD4+ T cells for 48 h on a 96-well U-bottom plate
without removal of unbound viral particles. Co-cultures were
performed in the presence or in the absence of 0.5 mM of
saquinavir. Infection of activated primary CD4+ T cells was
detected with FACS, measuring the intracellular p24Gag content
within the CD2-positive CD11c negative population of CD4+ T
cells employing the monoclonal antibodies p24Gag-FITC (KC57-
FITC, clone FH190-1-1, Beckman Coulter), CD2-PerCP Cy5.5
(clone RPA-2.10, BD Pharmingen), and CD11c-APC Cy7 (clone
Bu15, BioLegend). Co-cultures containing non-pulsed cells were
used as a background control for p24Gag labeling and used to set
up the marker at 0.5%. To detect the possible cell free virus
infection of activated CD4+ T cells, an equal MOI was added
directly to control wells lacking mDCs.
Statistical Analysis
Statistics were performed using GraphPad Prism v.5 software.
Supporting Information
Figure S1 Ganglioside structures. 2-D model of asialo-,
monosialo-, disialo-, trisialo-, and tetrasialo- gangliosides used in
this study.
(PDF)
Figure S2 Comparative fluorescence of tRed-containing
LUVs. Maximum emission fluorescence at 608 nm of
LUVHIV-tRed or LUVPOPC-tRed containing the molecules indicated
in the graphs. (A) Comparison of LUVHIV-tRed used in Figures 1
and 2; (B) comparison of LUVPOPC-tRed used in Figure 3; (C)
comparison of LUVHIV-tRed used in Figure 4; and (D) comparison
of LUVHIV-tRed used in Figure 5. Data show mean and SEM from
independent measurements from at least two distinct LUV
preparations.
(PDF)
Figure S3 FACS capture-profiles of distinct LUVs in
mDCs. Histograms showing a representative capture-profile from
Figure 1B, obtained pulsing mDCs derived from the same donor
with 100 mM of distinct fluorescent LUVHIV-tRed containing or not
Cer, GM3, GM2, or GM1a for 4 h at 37uC.
(PDF)
Figure S4 Polarized accumulation of ganglioside-con-
taining LUVs and VLPs in mDCs. Confocal microscopy
analysis of mDCs previously pulsed with 100 mM of GM1a, GM2,
and GM3 containing LUVHIV-tRed and then exposed to 75 ng of
VLPHIV-Gag-eGFP Gag as in Figure 2B. 3-D reconstructions of the
x-y sections collected throughout the whole mDC z volume every
0.1 mm. Isosurface representation of DAPI stained nucleus is
shown, computing the maximum intensity fluorescence within a 3-
D volumetric x-y-z data field, where VLPHIV-Gag-eGFP and
ganglioside-containing LUVHIV-tRed polarized towards the same
area of mDCs.
(PDF)
Figure S5 Binding of distinct LUVs to mDCs. (A)
Comparative mDC binding of LUVHIV-tRed containing GM3,
Cer, or PS treated or not with C. perfringens neuraminidase for
12 h prior to addition to cells. A total of 26105 DCs were pulsed
for 20 min at 37uC with 100 mM of LUV, washed with PBS, and
assessed by FACS to obtain the percentage of tRed-positive cells.
Data show mean values and SEM of cells from three donors.
mDCs bound significantly higher amounts of untreated GM3
containing LUVHIV-tRed than neuraminidase treated liposomes
(p = 0.024, paired t test). (B) Binding pattern analysis of mDCs
pulsed with LUVHIV-tRed containing GM3, Cer, or PS treated or
not with C. perfringens neuraminidase for 12 h prior addition to
cells. Cells were incubated for 20 min at 37uC (top images) or
2 h at 16uC (bottom images) with100 mM of LUV, washed with
PBS, and assessed by confocal microscopy. After 20 min at
37uC, liposomes remained randomly bound and no evident
polarization or internalization was detected, as seen in mDCs
incubated at 16uC to arrest endocytosis. Images show 3-D
reconstruction of the x-y sections collected throughout the whole
mDC z volume every 0.1 mm, computing the maximum intensity
fluorescence of the liposome red signal and DAPI-stained
nucleus.
(PDF)
Figure S6 Minimal energy structures of the different
gangliosides tested. Blue shadow indicates the proposed
sialyllactose viral attachment moiety recognized by mDCs. For
comparative purposes, GM4 and Asialo GM1 lacking sialyllactose
domains are also depicted.
(PDF)
Video S1 3-D reconstruction of an mDC pulsed with
GM3 containing LUVHIVtRed and then exposed to
VLPHIV-Gag-eGFP. Confocal microscopy analysis of an mDC
pulsed with GM3 containing LUVHIVtRed and then exposed to
VLPHIV-Gag-eGFP as in Figure 2b. The video shows a 3-D
reconstruction of the x-y sections collected throughout the whole
mDC z volume every 0.1 mm. Isosurface representation of DAPI
stained nucleus is depicted, computing the maximum intensity
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fluorescence of the sac-like compartment surface within a 3-D
volumetric x-y-z data field, where VLPHIV-Gag-eGFP and GM3-
containing LUVHIV-tRed are accumulated within the same
compartment.
(MOV)
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